3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Breast Neoplasms
22
Neoplasms
20
Lung Neoplasms
10
Colorectal Neoplasms
8
Uterine Cervical Neoplasms
6
Papillomavirus Infections
5
Head and Neck Neoplasms
5
Fatigue
5
Multiple Myeloma
4
Lymphoma
4
Hematologic Neoplasms
4
Urinary Bladder Neoplasms
3
Skin Neoplasms
3
Prostatic Neoplasms
3
Melanoma
3
Hematopoietic and Lymphoid System Neoplasm
3
Gastrointestinal Neoplasms
3
Sleep Wake Disorders
2
Skin Cancer Prevention
2
Obesity
2
Neoplasm Metastasis
2
Motor Activity
2
Leukemia, Myeloid, Acute
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Leukemia
2
Hematopoietic and Lymphatic System Neoplasm
2
Diabetes Mellitus
2
Depression
2
Caregiver
2
Cancer Survivor
2
Interventions
relacorilant
4
Hydrochlorothiazide
4
Nutrition Assessment
3
Labetalol
2
Bevacizumab
2
Angiotensin-Converting Enzyme Inhibitors
2
Amlodipine
2
ziprasidone
1
sacubitril and valsartan sodium hydrate drug combination
1
pembrolizumab
1
fimasartan
1
enzalutamide
1
clevidipine
1
cediranib
1
bicalutamide
1
aliskiren
1
Zolpidem
1
Warfarin
1
Vitamin D
1
Vecuronium Bromide
1
Vancomycin
1
Tumor Necrosis Factors
1
Tranexamic Acid
1
Tobramycin
1
Thiazides
1
Therapeutics
1
Surveys and Questionnaires
1
Sunitinib
1
Sulindac
1
Spironolactone
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Hypertension
×
Educational Status
×
Clear all
NCT03104543
2024-03-06
CHIIP
Fred Hutchinson Cancer Center
Phase NA
Completed
347 enrolled
10 charts